Shorter durations of antibiotic therapy in organ transplant

Curr Opin Organ Transplant. 2022 Aug 1;27(4):257-262. doi: 10.1097/MOT.0000000000000996.

Abstract

Purpose of review: Recent evidence supports shorter courses of antibiotics for several common infections and prophylactic indications. Unfortunately, solid organ transplant patients are often underrepresented or excluded from these studies. As a result, prolonged antibiotic durations are often used in clinical practice despite a lack of demonstrable benefit. This paper reviews recent publications addressing antibiotic duration of therapy in SOT recipients.

Recent findings: Although largely limited to observational studies, longer courses of antibiotics for surgical prophylaxis, urinary tract infections, and bloodstream infections have not demonstrated benefit compared to shorter courses. In some instances, longer courses of therapy have been associated with harm (i.e., adverse drug events and development of resistance).

Summary: Although the data remains limited, findings from retrospective studies evaluating shorter courses of antibiotics in SOT patients is encouraging. More robust research is desperately needed to define the optimal duration of antibiotics for common infections in SOT patients.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / adverse effects
  • Humans
  • Organ Transplantation* / adverse effects
  • Retrospective Studies
  • Time Factors
  • Transplant Recipients

Substances

  • Anti-Bacterial Agents